Omar Ali, Verpora’s Head of Payers, will be speaking at Model N Rainmaker, the industry’s leading conference focused on revenue management and compliance in life sciences. Drawing on Verpora’s direct experience supporting manufacturers through the IPAY26 and IPAY27 CMS negotiation rounds, Omar will share practical insight into how Medicare drug price negotiations are unfolding in practice and what they mean for pricing, access and portfolio strategy.
Featured Session
Lifting the Veil on CMS Drug Price Negotiations:
Negotiation Insights & Payer Impacts
DAY TWO March 3, 2026, 2:00 PM-2:50 PM (ET)
Omar Ali is joined by Drake Reiter, Pharmacy Director at Priority Health, to examine the realities of CMS/Medicare drug price negotiations and the implications for 2026 formulary bids.
Drawing on his experience as a former government payer at NICE and his current work supporting manufacturers through IPAY26 and IPAY27 negotiations, Omar will share practical insight into negotiation strategy, ICR submissions and CMS processes. The session will explore how government payer psychology influences pricing outcomes and how manufacturers can prepare for high-stakes engagement under the IRA framework.
Drake will provide the payer perspective, outlining the impact of Maximum Fair Price and Most Favored Nation dynamics, Part D redesign and 340B considerations. The discussion will address both intended and unintended consequences shaping pricing and access in the current environment.
Together, the session offers a structured view of how CMS negotiations are unfolding and what they mean for manufacturers navigating pricing, access and portfolio strategy.
Omar Ali
Head of Payers, Verpora
& Former Adviser to NICE
About Omar Ali
Drake Reiter
Pharmacy Director at Priority Health, USA
More Info & Registration
More information and registration directly via the Model N | Rainmaker Conference website…